Ataxin 2 (ATXN2) (Middle Region) Peptid
Kurzübersicht für Ataxin 2 (ATXN2) (Middle Region) Peptid (ABIN8095115)
Target
Quelle
Applikation
-
-
Protein Region
- Middle Region
-
Verwendungszweck
- ATXN2 Peptide - middle region
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Kommentare
-
This is a synthetic peptide designed for use in combination with anti-ATXN2 antibody ( ARP38210_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- Ataxin 2 (ATXN2)
-
Hintergrund
-
Background Information: The autosomal dominant cerebellar ataxias (ADCA) are a heterogeneous group of neurodegenerative disorders characterized by progressive degeneration of the cerebellum, brain stem and spinal cord. Clinically, ADCA has been divided into three groups: ADCA ty
Alternative Symbols: ATX2, FLJ46772, SCA2, TNRC13
-
Molekulargewicht
- 140kDa
-
Gen-ID
- 6311
-
NCBI Accession
- NP_002964
-
UniProt
- Q99700
Target
-